Francesco Costa

Francesco Costa is an Associate Professor of Practice in Government, Health & Not for Profit at SDA Bocconi School of Management, where he has been a faculty member since 2012. His most recent achievements include serving as a member of research consortia for European Horizon projects, joining the Steering Committee of the PhD Program in Translational Medicine at the University of Milan in 2024, and coordinating the CERGAS Pharmaceutical Observatory (OSFAR) since 2023. He has also contributed to numerous scientific conferences and roundtables on pharmaceutical care governance.

Initially focused primarily on the CERGAS Pharmaceutical Observatory, part of the Centre for Research on Health and Social Care Management, he has progressively expanded his work to include economic evaluation in healthcare, Health Technology Assessment, and Market Access. His current activities focus on three main areas: economic evaluations of health technologies, including cost-effectiveness analysis, cost-utility analysis, and budget impact analysis; analysis of the pharmaceutical and medical device markets in terms of performance, innovation, and responses to public policy; and Market and Patient Access.

Since 2018, he has directed several editions of executive education programs on access to medicines. He teaches Pharmaceutical Policy in the Master in Healthcare Management (MIMS) at SDA Bocconi and has directed numerous programs for professionals working in pharmaceutical and medical technology companies. He has published in national and international journals and contributed chapters to several editions of the OASI Report.

He is the author of articles published in Il Sole 24 Ore Sanità, a book on the organization and management of clinical trials, and a chapter in the volume L’Osservatorio del farmaco 2018. He also serves as an expert on advisory boards for pharmaceutical and medical device companies. Before joining SDA Bocconi, he worked for two major multinational pharmaceutical companies in Market Access and New Business Development.

He holds a Second-Level Specialized Master in Healthcare Management from SDA Bocconi and a PhD in Morphological Sciences from the University of Milan. He previously earned a degree in Medical Biotechnology from the same university, graduating with full marks.